Heart Test Laboratories (NASDAQ:HSCS – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Ascendiant Capital Markets in a note issued to investors on Monday, Benzinga reports. They presently have a $15.00 target price on the stock. Ascendiant Capital Markets’ target price suggests a potential upside of 391.80% from the company’s current price.
Heart Test Laboratories Stock Performance
HSCS stock traded up $0.06 during midday trading on Monday, reaching $3.05. 6,467 shares of the company traded hands, compared to its average volume of 56,989. The firm has a market capitalization of $2.00 million, a price-to-earnings ratio of -0.06 and a beta of 3.13. The business has a 50 day moving average of $3.40 and a 200-day moving average of $6.57. Heart Test Laboratories has a 52-week low of $2.36 and a 52-week high of $52.00.
Heart Test Laboratories Company Profile
Featured Articles
- Five stocks we like better than Heart Test Laboratories
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- The Average 401k Balance by Age Explained
- What is MarketRankā¢? How to Use it
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Stock Analyst Ratings and Canadian Analyst Ratings
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.